25 General introduction 1. Wimo A, et al. The worldwide costs of dementia 2015 and comparisons with 2010. Alzheimers Dement. Jan 2017;13(1):1-7. doi:10.1016/j. jalz.2016.07.150 2. Bo L, et al. Grey matter pathology in multiple sclerosis. Acta Neurol Scand Suppl. 2006;183:4850. doi:10.1111/j.1600-0404.2006.00615.x 3. Cova I, et al. Worldwide trends in the prevalence of dementia. J Neurol Sci. Aug 15 2017;379:259-260. doi:10.1016/j.jns.2017.06.030 4. Perry VH. The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease. Brain Behav Immun. Sep 2004;18(5):407-13. doi:10.1016/j. bbi.2004.01.004 5. Hickman S, et al. Microglia in neurodegeneration. Nat Neurosci. Oct 2018;21(10):1359-1369. doi:10.1038/s41593-018-0242-x 6. McKenzie IA, et al. Motor skill learning requires active central myelination. Science. Oct 17 2014;346(6207):318-22. doi:10.1126/ science.1254960 7. Amor S, et al. Inflammation in neurodegenerative diseases–an update. Immunology. 2014;142(2):151-166. 8. Myall DJ, et al. Parkinson’s in the oldest old: Impact on estimates of future disease burden. Parkinsonism Relat Disord. Sep 2017;42:78-84. doi:10.1016/j.parkreldis.2017.06.018 9. Tysnes OB, et al. Epidemiology of Parkinson’s disease. J Neural Transm (Vienna). Aug 2017;124(8):901-905. doi:10.1007/s00702-0171686-y 10. Rawlins MD, et al. The Prevalence of Huntington’s Disease. Neuroepidemiology. 2016;46(2):144-53. doi:10.1159/000443738 11. Verhaart IEC, et al. Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy- a literature review. Orphanet J Rare Dis. Jul 4 2017;12(1):124. doi:10.1186/s13023-017-0671-8 12. Arthur KC, et al. Projected increase in amyotrophic lateral sclerosis from 2015 to 2040. Nat Commun. Aug 11 2016;7:12408. doi:10.1038/ncomms12408 13. Mohan KM, et al. Risk and cumulative risk of stroke recurrence: a systematic review and meta-analysis. Stroke. May 2011;42(5):1489-94. doi:10.1161/ STROKEAHA.110.602615 14. Wong CH, et al. Prolonged Activation of Invariant Natural Killer T Cells and TH2-Skewed Immunity in Stroke Patients. Front Neurol. 2017/01/19 2017;8:6. doi:10.3389/fneur.2017.00006 15. Nguyen R, et al. The International Incidence of Traumatic Brain Injury: A Systematic Review and Meta-Analysis. Can J Neurol Sci. Nov 2016;43(6):774-785. doi:10.1017/cjn.2016.290 16. Zheng YH, et al. The Role of IL-27 and its Receptor in the Pathogenesis of HIV/AIDS and Anti-viral Immune Response. Curr HIV Res. 2017/08/25 2017;15(4):279-284. doi:10.2174/157016 2X15666170517130339 17. Harrison LH, et al. Global epidemiology of meningococcal disease. Vaccine. Jun 24 2009;27 Suppl 2:B51-63. doi:10.1016/j.vaccine.2009.04.063 18. Ribes S, et al. The Early Adaptive Immune Response in the Pathophysiological Process of Pneumococcal Meningitis. J Infect Dis. Jan 1 2017;215(1):150-158. doi:10.1093/infdis/jiw517 19. Deeks SG. HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med. 2011/02/18 2011;62(1):141-55. doi:10.1146/ annurev-med-042909-093756 20. Amor S, et al. Imaging immunological processes from blood to brain in amyotrophic lateral sclerosis. Clin Exp Immunol. Dec 2021;206(3):301-313. doi:10.1111/cei.13660 21. Ngugi AK, et al. Incidence of epilepsy: a systematic review and meta-analysis. Neurology. Sep 6 2011;77(10):1005-12. doi:10.1212/ WNL.0b013e31822cfc90 22. Singh A, et al. The Epidemiology of Global Epilepsy. Neurol Clin. Nov 2016;34(4):837-847. doi:10.1016/j.ncl.2016.06.015 23. Baxter AJ, et al. The epidemiology and global burden of autism spectrum disorders. Psychol Med. Feb 2015;45(3):601-13. doi:10.1017/ S003329171400172X 24. Careaga M, et al. Immune Endophenotypes in Children With Autism Spectrum Disorder. Biol Psychiatry. Mar 1 2017;81(5):434-441. doi:10.1016/j.biopsych.2015.08.036 25. Scott JG. Environmental Contributions to Autism: Explaining the Rise in Incidence of Autistic Spectrum Disorders. Journal of Enviromental Immunology and Toxicology. 2013;1(2):75. doi:10.7178/jeit.7 26. Ferrari AJ, et al. Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature. Psychol Med. Mar 2013;43(3):471-81. doi:10.1017/ S0033291712001511 27. Hidaka BH. Depression as a disease of modernity: explanations for increasing prevalence. J Affect Disord. Nov 2012;140(3):205-14. doi:10.1016/j. jad.2011.12.036 28. Hughes MM, et al. Stress-Related Immune Markers in Depression: Implications for Treatment. Int J Neuropsychopharmacol. Jun 2016;19(6):pyw001. doi:10.1093/ijnp/pyw001 29. Burns JK, et al. Income inequality and schizophrenia: increased schizophrenia incidence in countries with high levels of income inequality. Int J Soc Psychiatry. Mar 2014;60(2):185-96. doi:10.1177/0020764013481426 30. Karpinski P, et al. Reduced number of peripheral natural killer cells in schizophrenia but not in bipolar References
RkJQdWJsaXNoZXIy MTk4NDMw